Drug immunotargeting for carcinomas: a reality at last?
Casazza
A M
AM
Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, NJ.
Trail
P A
PA
Hellström
K E
KE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D003110:Colonic Neoplasms / Q000628:therapy; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation
D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D004317:Doxorubicin